Disagree
Home Swiss Remedies Swiss Remedies
Naproxen 220
Naproxen 220 - Swiss Remedies

Naproxen 220 - Swiss Remedies

Brand:
Category:
Substance:
Dosage:
220 mg/tab
Package:
100 tablets
Price:
0
See options
Product Overview

Widely known for its anti-inflammatory effects, naproxen has emerged as a potential antiviral agent against SARS-CoV-2. By targeting the viral nucleoprotein (N), naproxen impedes RNA binding and oligomerization processes critical for viral replication. Unlike other NSAIDs, it effectively reduced SARS-CoV-2 replication in cell-based studies and preserved epithelial integrity. Naproxen’s combination of antiviral and anti-inflammatory actions positions it as a promising, affordable treatment for COVID-19.

References:

Terrier, O., Dilly, S., Pizzorno, A., Chalupska, D., Humpolickova, J., Bouřa, E., Berenbaum, F., Quideau, S., Lina, B., Fève, B., Adnet, F., Sabbah, M., Rosa-Calatrava, M., Maréchal, V., Henri, J., and Slama-Schwok, A., 2021. Naproxen exhibits antiviral and anti-inflammatory properties against SARS-CoV-2. Molecules.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Naproxen 220 by Swiss Remedies, consult with your doctor or healthcare professional.

Explore More Products
FAQ
How is naproxen different from other NSAIDs in treating COVID-19?
Unlike NSAIDs such as ibuprofen or celecoxib, naproxen specifically targets the viral nucleoprotein while also controlling inflammation, giving it dual-action benefits.
References:

Terrier, O., Dilly, S., Pizzorno, A., Chalupska, D., Humpolickova, J., Bouřa, E., Berenbaum, F., Quideau, S., Lina, B., Fève, B., Adnet, F., Sabbah, M., Rosa-Calatrava, M., Maréchal, V., Henri, J., and Slama-Schwok, A., 2021. Naproxen exhibits antiviral and anti-inflammatory properties against SARS-CoV-2. Molecules.

Can naproxen reduce the cytokine storm in severe COVID-19 cases?
Yes, naproxen's anti-inflammatory properties may help modulate the immune response and reduce the cytokine storm in severe cases.
References:

Terrier, O., Dilly, S., Pizzorno, A., Chalupska, D., Humpolickova, J., Bouřa, E., Berenbaum, F., Quideau, S., Lina, B., Fève, B., Adnet, F., Sabbah, M., Rosa-Calatrava, M., Maréchal, V., Henri, J., and Slama-Schwok, A., 2021. Naproxen exhibits antiviral and anti-inflammatory properties against SARS-CoV-2. Molecules.

Is naproxen safe for COVID-19 patients?
Current research suggests naproxen is safe for COVID-19 patients and may reduce symptoms, but further clinical trials are needed for conclusive evidence.
References:

Terrier, O., Dilly, S., Pizzorno, A., Chalupska, D., Humpolickova, J., Bouřa, E., Berenbaum, F., Quideau, S., Lina, B., Fève, B., Adnet, F., Sabbah, M., Rosa-Calatrava, M., Maréchal, V., Henri, J., and Slama-Schwok, A., 2021. Naproxen exhibits antiviral and anti-inflammatory properties against SARS-CoV-2. Molecules.